Patents by Inventor Motoyasu OONISHI

Motoyasu OONISHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230210860
    Abstract: A method for treating an influenza virus infection is described. The disclosed method generally involves administering an effective amount of a compound (A), for example baloxavir marboxil, and a compound (B), for example a neuraminidase inhibor, to a subject that (1) has an influenza virus infection, (2) has been symptomatic of the influenza virus infection for no more than 96 hours, and (3) further has at least one severe influenza condition selected from the following: (a) being hospitalized due to severe influenza virus infection, (b) requiring an extension of hospitalization because of the influenza virus infection during the hospitalization, (c) having a National Early Warning Score 2 of four or more, (d) being on support for respiration, and (e) having at least one complication attributable to the influenza virus infection that necessitates hospitalization.
    Type: Application
    Filed: August 8, 2022
    Publication date: July 6, 2023
    Inventors: Takeki UEHARA, Toru ISHIBASHI, Takao SHISHIDO, Keita FUKAO, Motoyasu OONISHI, Barry CLINCH, Jaspinder RANDHAWA
  • Publication number: 20220008429
    Abstract: A method for treating an influenza virus infection is described. The disclosed method generally involves administering an effective amount of a compound (A), for example baloxavir marboxil, and a compound (B), for example a neuraminidase inhibor, to a subject that (1) has an influenza virus infection, (2) has been symptomatic of the influenza virus infection for no more than 96 hours, and (3) further has at least one severe influenza condition selected from the following: (a) being hospitalized due to severe influenza virus infection, (b) requiring an extension of hospitalization because of the influenza virus infection during the hospitalization, (c) having a National Early Warning Score 2 of four or more, (d) being on support for respiration, and (e) having at least one complication attributable to the influenza virus infection that necessitates hospitalization.
    Type: Application
    Filed: March 20, 2020
    Publication date: January 13, 2022
    Inventors: Takeki UEHARA, Toru ISHIBASHI, Takao SHISHIDO, Keita FUKAO, Motoyasu OONISHI, Barry CLINCH, Jaspinder RANDHAWA
  • Publication number: 20200297731
    Abstract: A method for treating an influenza virus infection is described. The disclosed method generally involves administering an effective amount of a compound (A), for example baloxavir marboxil, and a compound (B), for example a neuraminidase inhibor, to a subject that (1) has an influenza virus infection, (2) has been symptomatic of the influenza virus infection for no more than 96 hours, and (3) further has at least one severe influenza condition selected from the following: (a) being hospitalized due to severe influenza virus infection, (b) requiring an extension of hospitalization because of the influenza virus infection during the hospitalization, (c) having a National Early Warning Score 2 of four or more, (d) being on support for respiration, and (e) having at least one complication attributable to the influenza virus infection that necessitates hospitalization.
    Type: Application
    Filed: March 20, 2020
    Publication date: September 24, 2020
    Inventors: Takeki UEHARA, Toru ISHIBASHI, Takao SHISHIDO, Keita FUKAO, Motoyasu OONISHI, Barry CLINCH, Jaspinder RANDHAWA